Tekla Capital Management’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-529,226
| Closed | -$5.13M | – | 202 |
|
|
2021
Q2 | $5.13M | Hold |
529,226
| – | – | 0.17% | 117 |
|
|
2021
Q1 | $5.68M | Sell |
529,226
-288,558
| -35% | -$3.1M | 0.2% | 108 |
|
|
2020
Q4 | $12M | Buy |
817,784
+369,735
| +83% | +$5.44M | 0.42% | 69 |
|
|
2020
Q3 | $6.37M | Hold |
448,049
| – | – | 0.24% | 94 |
|
|
2020
Q2 | $3.63M | Hold |
448,049
| – | – | 0.14% | 125 |
|
|
2020
Q1 | $1.81M | Buy |
448,049
+1,950
| +0.4% | +$7.88K | 0.08% | 140 |
|
|
2019
Q4 | $459K | Hold |
446,099
| – | – | 0.02% | 197 |
|
|
2019
Q3 | $137K | Hold |
446,099
| – | – | 0.01% | 186 |
|
|
2019
Q2 | $146K | Hold |
446,099
| – | – | 0.01% | 194 |
|
|
2019
Q1 | $294K | Hold |
446,099
| – | – | 0.01% | 188 |
|
|
2018
Q4 | $763K | Sell |
446,099
-22,300
| -5% | -$38.1K | 0.03% | 174 |
|
|
2018
Q3 | $2.72M | Hold |
468,399
| – | – | 0.1% | 128 |
|
|
2018
Q2 | $2.81M | Hold |
468,399
| – | – | 0.11% | 120 |
|
|
2018
Q1 | $3.37M | Buy |
468,399
+18,399
| +4% | +$132K | 0.13% | 109 |
|
|
2017
Q4 | $3.29M | Sell |
450,000
-50,000
| -10% | -$365K | 0.13% | 105 |
|
|
2017
Q3 | $2.58M | Hold |
500,000
| – | – | 0.09% | 108 |
|
|
2017
Q2 | $1.98M | Buy |
+500,000
| New | +$1.98M | 0.07% | 112 |
|
|
2015
Q4 | – | Sell |
-65,000
| Closed | -$847K | – | 140 |
|
|
2015
Q3 | $847K | Hold |
65,000
| – | – | 0.03% | 128 |
|
|
2015
Q2 | $1.42M | Buy |
+65,000
| New | +$1.42M | 0.05% | 94 |
|